Oxo-substituted imidazo[1,2B]pyridazines, their preparation and use as pharmaceuticals

US8653076B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Olaf Prien · Berlin, DE
• Knut Eis · Berlin, DE
• Benjamin Bader · Berlin, DE
• Judith Guenther · Berlin, DE
• Arne Von Bonin · Hohen Neuendorf, DE

Key dates

• Filing date: Jun 20, 2007
• Grant date: Feb 18, 2014
• Expiry date: Jun 20, 2027

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to novel inhibitors of kinases of the general formula (I):in which Q and R1 are defined in the claims, method for preparing such inhibitors, intermediates for preparing such inhibitors and uses of such inhibitors.